PUBLISHER: The Business Research Company | PRODUCT CODE: 1760478
PUBLISHER: The Business Research Company | PRODUCT CODE: 1760478
An automatic immunohistochemical staining instrument is a laboratory device designed to automate the staining of tissue samples for detecting specific proteins or antigens. Its main function is to improve the accuracy, consistency, and efficiency of immunohistochemistry (IHC) tests, which are vital for diagnosing diseases such as cancer by visualizing molecular markers in tissue sections.
The main product types include fully automated stainers, semi-automated stainers, and manual stainers. Fully automated stainers are advanced instruments that perform immunohistochemical or histological staining with minimal human input. The technologies used include slide staining, tissue staining, and fluorescent staining. Consumables involved in the process include antibodies, staining kits, slides, and coverslips. Applications cover oncology, cardiovascular diseases, neurological disorders, and infectious diseases. Key end-users include hospitals, diagnostic laboratories, academic institutions, and research laboratories.
The automatic immunohistochemical staining instrument market research report is one of a series of new reports from The Business Research Company that provides automatic immunohistochemical staining instrument market statistics, including automatic immunohistochemical staining instrument industry global market size, regional shares, competitors with a automatic immunohistochemical staining instrument market share, detailed automatic immunohistochemical staining instrument market segments, market trends and opportunities, and any further data you may need to thrive in the automatic immunohistochemical staining instrument industry. This automatic immunohistochemical staining instrument market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The automatic immunohistochemical staining instrument market size has grown strongly in recent years. It will grow from $1.22 billion in 2024 to $1.31 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to the increasing prevalence of chronic diseases, growing demand for personalized medicine, rising number of pathology laboratories, improved accuracy and reproducibility of results, expansion of research in molecular biology, and increasing government healthcare expenditure.
The automatic immunohistochemical staining instrument market size is expected to see strong growth in the next few years. It will grow to $1.73 billion in 2029 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to the increasing focus on early disease detection, growing geriatric population, expansion of healthcare infrastructure in emerging markets, rising investment in cancer research, demand for standardized diagnostic procedures, and growth in biotechnology and pharmaceutical research and development activities. Major trends in the forecast period include integration with artificial intelligence for image analysis, development of cloud-based data management systems, miniaturization of staining instruments, enhanced multiplexing capabilities, automation of slide preparation and staining, and use of advanced robotics for precision handling.
The increasing prevalence of chronic diseases is expected to drive the growth of the automatic immunohistochemical staining instrument market. Chronic diseases refer to long-term medical conditions that typically progress gradually and require continuous management. These include diabetes, heart disease, hypertension, arthritis, chronic respiratory diseases, cancer, and obesity. The rise in chronic diseases is linked to lifestyle changes, poor diet, and insufficient physical activity, all contributing to long-term health complications. Automatic immunohistochemical staining instruments improve diagnostic capabilities by offering precise and efficient tissue analysis, making them crucial for detecting chronic diseases. These instruments reduce manual labor with fast, automated staining processes, improving diagnostic accuracy and enabling earlier disease detection. For example, in June 2024, the National Health Service (NHS) in the UK reported that 3,615,330 individuals registered with a general practitioner (GP) were diagnosed with non-diabetic hyperglycemia or pre-diabetes in 2023, an 18% increase from 3,065,825 cases in 2022. Therefore, the growing prevalence of chronic diseases is driving the expansion of the automatic immunohistochemical staining instrument market.
Companies in the automatic immunohistochemical staining instrument market are focusing on developing innovative solutions, such as antibody alternative reagents, to enhance the accuracy, efficiency, and versatility of tissue analysis while reducing costs and improving reproducibility. An antibody alternative reagent is a non-antibody molecule, such as an aptamer, affirmer, or antibody mimetic, that can specifically bind to target antigens and be used instead of traditional antibodies in research, diagnostic, or therapeutic applications. For example, in March 2023, Aptamer Group plc, a U.K.-based biotechnology company, launched Optimer-Fc, a new reagent solution for automated immunohistochemistry (IHC) workflows. Optimer-Fc offers an innovative antibody alternative for immunohistochemistry, expanding target detection capabilities and enhancing assay selectivity. It integrates seamlessly into automated IHC workflows, allowing for the accurate identification of both established and novel biomarkers.
In July 2023, Bio-Techne Corporation, a U.S.-based biotechnology and life sciences company, acquired Lunaphore Technologies SA for $170.1 million. This acquisition strengthens Bio-Techne's position in spatial biology and automated IHC by integrating Lunaphore's microfluidic staining platforms, enhancing high-throughput tissue analysis and precision research. Lunaphore Technologies SA is a Switzerland-based biotech company specializing in automated immunohistochemistry (IHC) and immunofluorescence (IF) staining instruments.
Major players in the automatic immunohistochemical staining instrument market are F. Hoffmann-La Roche AG, Merck & Co. Inc., Thermo Fisher Scientific, Sophionix, Agilent Technologies, Leica Biosystems, PathnSitu Biotechnologies, Sakura Finetek, Olympus Corporation, Biocare Medical, Celnovte Biotechnology Co., Ltd., Celnovte Biotechnology Co. Ltd, BioGenex Laboratories, Diagnostic BioSystems, ADS Biotec, Wondfo Biotech, Fuzhou Maixin Biotech Co. Ltd., Shenzhen Dartmon Biotechnology Co., Ltd, CEM Corporation, Shenzhen Dartmon Biotechnology Co. Ltd.
North America was the largest region in the automatic immunohistochemical staining instrument market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in automatic immunohistochemical staining instrument report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the automatic immunohistochemical staining instrument market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The automatic immunohistochemical staining instrument market consists of sales of slide holders, reagent dispensers, detection systems, and associated consumables such as antibodies, detection kits, and chromogens used in the immunohistochemical staining process. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Automatic Immunohistochemical Staining Instrument Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on automatic immunohistochemical staining instrument market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for automatic immunohistochemical staining instrument ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The automatic immunohistochemical staining instrument market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.